Vertiv Surges; GE Healthcare Rises; Boston Scientific Falls on Profit Outlook


Vertiv raises 2026 sales and earnings outlook on booming data-center demand; GE Healthcare lifts full-year EPS guidance after a Q3 beat; Boston Scientific cuts EPS outlook, shares slump.

Editorial companion

What stands out

Bloomberg highlights three earnings stories that moved stocks today: Vertiv raised its multi-year sales and profit outlook on booming data-center equipment demand, GE Healthcare lifted full-year adjusted earnings per share guidance after a quarter that beat expectations, and Boston Scientific trimmed EPS guidance, sending its shares lower. The clip matters because it shows how the same earnings season can create winners and losers within industrial and medical-equipment sectors, Vertiv’s upside revision landed as a clear growth narrative while Boston Scientific’s weaker profit outlook forced re-pricing.